NYSE - Delayed Quote • USD
ResMed Inc. (RMD)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:58 PM EDT
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
4,504,077.00
4,222,993.00
3,578,127.00
3,196,825.00
2,957,013.00
Cost of Revenue
2,021,945.00
1,867,331.00
1,553,816.00
1,357,725.00
1,239,227.00
Gross Profit
2,482,132.00
2,355,662.00
2,024,311.00
1,839,100.00
1,717,786.00
Operating Expense
1,266,905.00
1,203,665.00
1,022,161.00
926,749.00
908,727.00
Operating Income
1,215,227.00
1,151,997.00
1,002,150.00
912,351.00
809,059.00
Net Non Operating Interest Income Expense
-58,669.00
-47,379.00
-22,312.00
-23,627.00
-39,356.00
Other Income Expense
-58,733.00
-2,954.00
-19,355.00
-5,062.00
-36,615.00
Pretax Income
1,097,825.00
1,101,664.00
960,483.00
883,662.00
733,088.00
Tax Provision
207,439.00
204,108.00
181,046.00
409,157.00
111,414.00
Net Income Common Stockholders
890,386.00
897,556.00
779,437.00
474,505.00
621,674.00
Diluted NI Available to Com Stockholders
890,386.00
897,556.00
779,437.00
474,505.00
621,674.00
Basic EPS
6.06
6.12
5.34
3.27
4.31
Diluted EPS
6.04
6.09
5.30
3.24
4.27
Basic Average Shares
147,033.00
146,765.00
146,066.00
145,313.00
144,338.00
Diluted Average Shares
147,557.50
147,455.00
147,043.00
146,451.00
145,652.00
Total Operating Income as Reported
1,140,030.00
1,131,871.00
1,000,286.00
903,678.00
809,659.00
Total Expenses
3,288,850.00
3,070,996.00
2,575,977.00
2,284,474.00
2,147,954.00
Net Income from Continuing & Discontinued Operation
890,386.00
897,556.00
779,437.00
474,505.00
621,674.00
Normalized Income
934,969.17
897,473.69
780,950.57
480,836.29
621,165.19
Interest Income
--
--
--
362.00
1,021.00
Interest Expense
--
--
--
23,989.00
40,377.00
Net Interest Income
-58,669.00
-47,379.00
-22,312.00
-23,627.00
-39,356.00
EBIT
1,215,227.00
1,151,997.00
1,002,150.00
912,351.00
809,059.00
EBITDA
1,430,028.00
1,349,559.00
1,195,991.00
1,103,869.00
990,432.00
Reconciled Cost of Revenue
1,855,707.00
1,711,789.00
1,391,053.00
1,197,285.00
1,087,946.00
Reconciled Depreciation
214,801.00
197,562.00
193,841.00
191,518.00
181,373.00
Net Income from Continuing Operation Net Minority Interest
890,386.00
897,556.00
779,437.00
474,505.00
621,674.00
Total Unusual Items Excluding Goodwill
-54,970.00
101.00
-1,864.00
-8,673.00
600.00
Total Unusual Items
-54,970.00
101.00
-1,864.00
-8,673.00
600.00
Normalized EBITDA
1,484,998.00
1,349,458.00
1,197,855.00
1,112,542.00
989,832.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-10,386.83
18.69
-350.43
-2,341.71
91.19
6/30/2020 - 6/2/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RGEN Repligen Corporation
166.58
+0.56%
WST West Pharmaceutical Services, Inc.
360.43
-2.10%
ISRG Intuitive Surgical, Inc.
375.33
+0.59%
BDX Becton, Dickinson and Company
231.55
+0.46%
COO The Cooper Companies, Inc.
88.84
-1.21%
BAX Baxter International Inc.
40.13
-0.25%
HOLX Hologic, Inc.
75.98
+0.36%
ATR AptarGroup, Inc.
143.33
+2.25%
TFX Teleflex Incorporated
206.71
0.00%
STAA STAAR Surgical Company
46.96
+0.15%